Dr Lalchandani Labs: No Price-Sensitive Information Pending

Company responds to BSE query on share price movement under SEBI LODR Regulation 30.
Confirms no pending price-sensitive information exists that could impact share price.
Attributes recent share price movement entirely to market-driven factors.
Affirms compliance with all mandatory disclosure regulations to the stock exchange.